Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein

Virology

Volumn 273, Issue 1, 2000, Pages 21-35

  Gedvilaite, Alma ^a   Frömmel, Cornelius ^b   Sasnauskas, Kestutis ^a   Micheel, Burkhard ^c   Özel, Muhsin ^d   Behrsing, Olaf ^c   Staniulis, Juozas ^e   Jandrig, Burkhard ^f   Scherneck, Siegfried ^f   Ulrich, Rainer ^b  

^a VILNIUS UNIVERSITY   (Lithuania)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF POTSDAM   (Germany)

^d ROBERT KOCH INSTITUTE   (Germany)

^e INSTITUTE OF BOTANY   (Lithuania)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE;

ANTIBODY RESPONSE; ANTIGENICITY; ARTICLE; HEPATITIS B VIRUS; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN MODIFICATION; VACCINE PRODUCTION; VIRUS PARTICLE;

CRICETINAE; DNA VIRUSES; HAMSTER PARVOVIRUS; HAMSTER POLYOMAVIRUS; HEPATITIS B VIRUS; MIRIDAE; POLYOMAVIRUS;

EID: 0342323856     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0392     Document Type: Article

References (47)

1. Ada G., Ramsay A. Vaccines, Vaccination and the Immune Response. 1997;Lippincott-Raven, Philadelphia/New York.
2. Adams S. E., Burns N. R., Layton G. T., Kingsman A. J. Hybrid Ty virus-like particles. Int. Rev. Immunol. 11:1994;133-141.
3. Babe L. M., Brew K., Matsuura S. E., Scott W. A. Epitopes on the major capsid protein of simian virus 40. J. Biol. Chem. 264:1988;2665-2671.
4. Belnap D. M., Olson N. H., Cladel N. M., Newcomb W. W., Brown J. C., Kreider J. W., Christensen N. D., Baker T. S. Conserved features in papillomavirus and polyomavirus capsids. J. Mol. Biol. 259:1996;249-263.
5. Bernstein F. C., Koetzle T. F., Williams G. J. B., Meyer E. F. Jr., Brice M. D., Rodgers J. R., Kennard O., Shimanouchi T., Tasumi M. The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112:1977;535-542.
6. Blundell T. L., Johnson L. N. Protein Crystallography. 1976;Academic Press, London/New York/San Francisco. p. 121-123.
7. Borisova G., Borschukova O., Skrastina D., Dislers A., Ose V., Pumpens P., Grens E. Behavior of a short preS1 epitope on the surface of hepatitis B core particles. Biol. Chem. 380:1999;315-324.
8. Borisova G., Borschukova Wanst O., Mezule G., Skrastina D., Petrovskis I., Dislers A., Pumpens P., Grens E. Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen. Intervirology. 39:1996;16-22.
9. Böttger M., Scherneck S. Heterogeneity, molecular weight and stability of an oncogenic papovavirus of the Syrian hamster. Arch. Geschwulstforsch. 55:1985;225-233.
10. Broekhuijsen M. P., van Rijn J. M. M., Blom A. J. M., Pouwels P. H., Enger-Valk B. E., Brown F., Francis M. J. Fusion proteins with multiple copies of the major antigenic determinant of foot and mouth disease virus protect both the natural host and laboratory animals. J. Gen. Virol. 68:1987;3137-3143.
11. Chang D., Liou Z. M., Ou W. C., Wang K. Z., Wang M., Fung C. Y., Tsai R. T. Production of the antigen and the antibody of the JC virus major capsid protein VP1. J. Virol. Methods. 59:1996;177-187.
12. Chen X. S., Stehle T., Harrison S. C. Interaction of polyomavirus internal protein VP2 with major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J. 17:1998;3233-3240.
13. Ciarlet M., Crawford S. E., Barone C., Bertolotti-Ciarlet A., Ramig R. F., Estes M. K., Conner M. E. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J. Virol. 72:1998;9233-9246.
14. Coligan J. E., Kruisbeek A. M., Margulies D. H., Shevach E. M., Strober W. Current Protocols in Immunology. 1997;Wiley and Sons, New York. p. 9.4.
15. Coursaget P., Lesage G., Le Cann P., Mayelo V., Bourdil C. Mapping of linear B-cell epitopes of hepatitis B surface antigen. Res. Virol. 142:1991;461-467.
16. Forstova J., Krauzewicz N., Sandig V., Elliott J., Palkova Z., Strauss M., Griffin B. E. Polyoma virus pseudocapsids as efficient carriers of heterologous DNA into mammalian cells. Hum. Gene Ther. 6:1995;297-306.
17. Garcea R. L., Salunke D. M., Caspar D. L. Site-directed mutation affecting polyomavirus capsid self-assembly in vitro. Nature. 329:1987;86-87.
18. Germaschewski V., Murray K. Screening a monoclonal antibody with a fusion-phage display library shows a discontinuity in a linear epitope within preS1 of hepatitis B virus. J. Med. Virol. 45:1995;300-305.
19. Gillock E. T., Rottinghaus S., Chang D., Cai X., Smiley A., An K., Consigli R. A. Polyomavirus major capsid protein VP1 is capable of packaging cellular DNA when expressed in the baculovirus system. J. Virol. 71:1997;2857-2865.
20. Gleiter S., Stubenrauch K., Lilie H. Changing the surface of a virus shell fusion of an enzyme to polyoma VP1. Prot. Sci. 8:1999;2562-2569.
21. Graffi A., Schramm T., Bender E., Bierwolf D., Graffi I. Über einen neuen virushaltigen Hauttumor beim Goldhamster. Arch. Geschwulstforsch. 30:1967;277-283.
22. Hassen Siray Özel M., Jandrig B., Voronkova T., Jia W., Zocher R., Arnold W., Scherneck S., Krüger D. H., Ulrich R. Capsid protein-encoding genes of hamster polyomavirus and properties of the viral capsid. Virus Genes. 18:1998;39-47.
23. Heermann K. H., Goldmann U., Schwartz W., Seyfarth T., Baumgarten H., Gerlich W. H. Large surface proteins of hepatitis B virus containing the pre-S sequence. J. Virol. 52:1984;396-402.
24. Holm L., Ouzounis C., Sander C., Tuparev G., Vriend G. A database of protein structure families with common folding motifs. Prot. Sci. 1:1992;1691-1698.
25. Holm L., Sander C. Touring protein fold space with Dali/FSSP. Nucleic Acids Res. 26:1998;316-319.
26. Jin L., Gibson P. E., Knowles W. A., Clewley J. P. BK virus antigenic variants: Sequence analysis within the capsid VP1 epitope. J. Med. Virol. 39:1993;50-56.
27. Kabsch W., Sander C. Dictionary of secondary structures in proteins. Biopolymers. 22:1983;2577-2637.
28. Krüger D. H., Ulrich R., Gerlich W. H. Chimeric virus-like particles as vaccines (Editorial). Biol. Chem. 380:1999;275-276.
29. Lachmann S., Meisel H., Muselmann C., Koletzki D., Gelderblom H. R., Borisova G., Krüger D. H., Pumpens P., Ulrich R. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology. 42:1999;51-56.
30. Liddington R. C., Yan Y., Moulai J., Sahli R., Benjamin T. L., Harrison S. C. Structure of simian virus 40 at 3.8-Å resolution. Nature. 354:1991;278-284.
31. Lindner W., Robey F. A. Automated synthesis and use of N-chloroacetyl-modified peptides for the preparation of synthetic peptide polymers and peptide-protein immunogens. Int. J. Pept. Prot. Res. 30:1987;794-800.
32. Lowy D. R., Schiller J. T. Papillomaviruses: Prophylactic vaccine prospects. Biochim. Biophys. Acta. 1423:1999;1-8.
33. McLinden J. H., Ploplis V. A., Fraser M. J., Rosen E. D. Expression of foreign epitopes on recombinant occlusion bodies of baculoviruses. Vaccine. 10:1992;231-237.
34. Micheel B., Scharte G. Multiple antigen injections decrease the yield of hybridomas producing monoclonal antibodies. Hybridoma. 12:1993;227-229.
35. Özel M., Pauli G., Gelderblom H. R. Electron spectroscopic imaging (ESI) of viruses using thin-section and immunolabelling preparations. Ultramicroscopy. 32:1990;35-41.
36. Pawlita M., Müller M., Oppenländer M., Zentgraf H. W., Herrmann M. DNA encapsidation by virus-like particles assembled in insect cells from the major capsid protein VP1 of B-lymphotropic papovavirus. J. Virol. 70:1996;7517-7526.
37. Pumpens P., Borisova G. P., Crowther R. A., Grens E. Hepatitis B core particles as epitope carriers. Intervirology. 38:1995;63-74.
38. Pumpens P., Grens E. Hepatitis B core particles as a universal display model: A structure-function basis for development. FEBS Lett. 442:1999;1-6.
39. Sasnauskas K., Buzaite O., Vogel F., Jandrig B., Razanskas R., Staniulis J., Scherneck S., Krüger D. H., Ulrich R. Yeast cells allow high-level expression and formation of polyomavirus-like particles. Biol. Chem. 380:1999;381-386.
40. Scherneck S., Feunteun J. The hamster polyomavirus. Barbanti Brodano G., Bendinelli M., Friedmann H. DNA Tumor Viruses: Oncogenic Mechanisms. 1995;1-14 Plenum Press, New York.
41. Sominskaya I., Pushko P., Dreilina D., Kozloskaya T., Pumpen P. Determination of the minimal length of preS1 epitope recognized by a monoclonal antibody which inhibits attachment of hepatitis B virus to hepatocytes. Med. Microbiol. Immunol. 181:1992;215-226.
42. Stoute J. A., Slaoui M., Heppner D. G., Momin P., Kester K. E., Desmons P., Wellde B. T., Garcon N., Krzych U., Marchand M., Ballou W. R., Cohen J. D. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336:1997;86-91.
43. Szomolanyi-Tsuda E., Le Q. P., Garcea R. L., Welsh R. M. T-cell-independent immunoglobulin G responses in vivo are elicited by live-virus infection but not by immunization with viral proteins or virus-like particles. J. Virol. 72:1998;6665-6670.
44. Touze A., Coursaget P. In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res. 26:1998;1317-1323.
45. Ulrich R., Koletzki D., Lachmann S., Lundkvist Å., Zankl A., Kazaks A., Kurth A., Gelderblom H. R., Borisova G., Meisel H., Krüger D. H. New chimeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: Immunogenicity and protection against virus challenge. J. Biotechnol. 73:1999;141-153.
46. Ulrich R., Nassal M., Meisel H., Krüger D. H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50:1998;141-182.
47. Wynne S. A., Crowther R. A., Leslie A. G. The crystal structure of the human hepatitis B virus capsid. Mol. Cell. 3:1999;771-780.